Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.
Access filings by selecting the date range and type using the drop-down menus.
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at email@example.com
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.